| 项目 | 本报告期 | 本报告期 比上年同 | | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | 期增减变 | 年初至报告期末 | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 345,179,582.58 | -12.17 | 1,188,509,072.63 | 8.73 | | 利润总额 | -79,241,287.34 | -315.69 | -21,198,154.19 | -115.23 | | 归属于上市公司股东的净利润 | -78.508.463.45 | -353.32 | -27,209,818.77 | -123.51 | | 归属于上市公司股东的扣除非 经常性损益的净利润 | -80,209,053.68 | -367.18 | -44.575.434.71 | -140.11 | | 经营活动产生的现金流量净额 | 不适用 | 不适用 | -403,852,005.54 | -1691.43 | | 基本每股收益(元/股) | -0.112 | -354.55 | -0.039 | ...

Core Insights - The company reported a revenue of 47.35 million yuan for the first half of 2025, representing a year-on-year decline of 17.15% [1] - The net profit attributable to shareholders was -14.82 million yuan, a decrease of 32.22% compared to the previous year [1] Financial Performance - Revenue for the first half of 2025: 47.35 million yuan, down 17.15% year-on-year [1] - Net profit attributable to shareholders: -14.82 million yuan, down 32.22% year-on-year [1] - Foreign revenue reached 9.44 million yuan, an increase of 7.60% year-on-year, driven by the recovery of import repair business and the export of gradient coils [1] Cost Management - Sales expenses decreased by 22.63% compared to the same period last year [1] - Management expenses reduced by 20.80% year-on-year [1] Research and Development - R&D expenses amounted to 16.50 million yuan, an increase of 34.79% year-on-year, accounting for 34.84% of total revenue [1] - Focus areas include MRI system integration technology, 7.0T and multi-core high-end RF detectors, and superconducting magnets [1] - Some R&D outcomes have already been applied to the company's products [1] Product Development - The company is expanding its medical imaging equipment product line and advancing new product registration and commercialization [1] - The digital X-ray machine (DR) has obtained medical device registration and is in the market promotion phase [1] - The CT project has completed prototype production and is in the new product registration review stage [1][2]